Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report - Wikidata - awgldk - TriplyDB

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

http://www.wikidata.org/entity/Q33454062

about

Advances and hurdles on the way toward a leprosy vaccine.Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy Inflammatory Mediators of Leprosy Reactional Episodes and Dental Infections: A Systematic Review The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy.Analysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India.Genetic variations and interactions in anti-inflammatory cytokine pathway genes in the outcome of leprosy: a study conducted on a MassARRAY platform.Circulating levels of insulin-like growth factor-I (IGF-I) correlate with disease status in leprosy.DNA Sensing via TLR-9 Constitutes a Major Innate Immunity Pathway Activated during Erythema Nodosum Leprosum.Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.Evaluation of gamma interferon (IFN-γ)-induced protein 10 responses for detection of cattle infected with Mycobacterium bovis: comparisons to IFN-γ responses.Leprosy Reactions Show Increased Th17 Cell Activity and Reduced FOXP3+ Tregs with Concomitant Decrease in TGF-β and Increase in IL-6 Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients.Leprosy reactions: coinfections as a possible risk factor.Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).A Missense LRRK2 Variant Is a Risk Factor for Excessive Inflammatory Responses in Leprosy.Is CXCL10/CXCR3 axis overexpression a better indicator of leprosy type 1 reaction than inducible nitric oxide synthase?Development of Type 2, But Not Type 1, Leprosy Reactions is Associated with a Severe Reduction of Circulating and In situ Regulatory T-Cells The involvement of endothelial mediators in leprosy.A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy.Leprosy: an overview of pathophysiology Genetics of leprosy reactions: an overview.Challenges in immunodiagnostic tests for leprosy.Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological condition.A new era of diagnostic modalities for type 1 leprosy reactions: Promise for the future Association of TNFSF8 regulatory variants with excessive inflammatory responses but not leprosy per se.Vitamin D receptor expression levels determine the severity and complexity of disease progression among leprosy reaction patients Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy.Complement activation in leprosy: a retrospective study shows elevated circulating terminal complement complex in reactional leprosy.Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions.World Leprosy Day 2015: renewing commitment for a leprosy free world!The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.miRNome Expression Analysis Reveals New Players on Leprosy Immune Physiopathology.Blood coagulation abnormalities in multibacillary leprosy patients.Comparison between microsatellites and Ml MntH gene as targets to identify Mycobacterium leprae by PCR in leprosy.Autophagy Impairment Is Associated With Increased Inflammasome Activation and Reversal Reaction Development in Multibacillary Leprosy.T-helper 17 cytokines expression in leprosy skin lesions

P2860

Q22305432-D31338A0-9F4C-4CB7-A23D-D1D3AE116727 Q26749927-10FE6EF9-7945-4EF0-B035-814F1B719568 Q26785530-73361F70-BA5C-40FF-9B45-1E3D687B015E Q30238551-984DDEF8-AC21-45F2-A6B4-F0EE7246B8B0 Q33847430-89C96D84-B4E4-495A-9A97-A67C1EA23044 Q34019660-CC1F519B-65C4-4725-BA42-A4D64AAA2F61 Q34099919-D27261BD-E748-4A2B-ABCA-F92484DA4BA0 Q34535803-D96FBDB6-4171-4DC8-B428-751CB3EE797E Q35066443-57866139-632A-4059-8059-A25D6D7EC1D6 Q35070041-E1952484-87ED-4532-A46D-6D4E4DAD1847 Q35805257-EF4C3B9E-8441-45CD-B431-C5812175DF12 Q35976768-E2189A27-9344-4C6A-9781-8E95CC97CE21 Q36169102-E08C89D8-0C68-4617-AD5C-8C2D1BE1AE01 Q36284796-C9129FFD-159A-4B28-B53F-7CE735114420 Q36286311-D3D34AA7-71E4-4E4B-A5D6-A55D3778F424 Q36546940-AE946F55-61F4-4969-A681-9BA3799AC0CD Q36639141-FEBFA8D9-FADB-4F9C-9F0A-B10A640F6205 Q36775999-433B4D57-A789-4131-B9B3-5BFA076697AD Q37343216-05047711-8AB5-41A5-A1A4-5355144D80D8 Q37695062-CE66E71D-3BEF-4638-911A-4C5EECD757E4 Q37705724-A35E4986-F1AD-4B47-B718-CE389DC42340 Q38044386-06E7D5F1-87B7-4F1A-9163-DCE3B2EF4734 Q38071237-6F69D148-ECFD-4F56-B0D7-22E1555717E9 Q38093850-9C7B743A-76A2-4CB7-9EC1-70FBA7FDABB9 Q38349738-8122A891-B963-4805-9B3A-78E75F94B21E Q38714931-36D65045-64C3-480C-B727-E915DB6921E8 Q39000852-2C47302D-EC9D-488E-A774-29933285CB7C Q39209622-B81F7114-C048-471A-A8D6-5CEEB25DEAAD Q39426951-BA971F69-E3D2-4CB0-8FDE-1F6260FD5A5D Q40838964-15CE8960-0BC0-4AC1-AE22-8A8193967D0C Q41013632-CFD580F7-45FF-405A-8A71-68565FE57C61 Q41130687-D6BC4BF3-2E67-4252-B76E-589F168A6308 Q42235469-AC3D5921-C63B-441A-BD5B-980D696FB8A3 Q42594790-319610D7-BBAD-4DE8-A03B-E67512BAC66E Q50285516-BAB19976-560D-478E-BCE6-E5C015E77E47 Q51415628-97E47D46-4B3F-4CEE-9E39-B50E2ECFE270 Q52642740-C91AF4F2-6BA4-4E60-8E4C-6CABAE3FBE90 Q54344457-6D4F7C51-31C8-4AD1-8B72-3B9F6D7557D7 Q55262167-5DD2D976-D8A0-490A-9914-00769E573CB8 Q56763812-AD251357-669C-49B4-95AF-76CB3409ECEA

P2860

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

http://www.wikidata.org/entity/Q33454062

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

@ast

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

@en

type

label

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

@ast

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

@en

prefLabel

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

@ast

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

@en

P1433

Q33454062-289AC035-0E15-445E-8DDA-9D4A16CEA5FD

P1476

Q33454062-54D0406A-40E1-4FD6-9A7A-1F01818B6BCE

P2093

Q33454062-26DB6072-02BE-47CA-B4FB-88BBAF0A82FD

Q33454062-6A94975E-879D-4410-BC79-5DA4ABC96F6A

Q33454062-90CB8C14-4C11-4BBD-A780-F01710AF8A73

Q33454062-A653DC46-F25F-48F7-B116-946A45442000

Q33454062-AB826470-82FF-468A-B9EF-2DB58BA2DD0B

Q33454062-B54697BB-EF8D-40CA-8DFD-E6FFDD5C7030

Q33454062-F54ACA2B-E8CD-461D-9E5A-EEEE68A8E2F4

P2860

Q33454062-02933894-C3C1-4691-AA4E-C68FC62D2A26

Q33454062-0AA0A2D0-51E8-4261-BE6A-D4E01E1334D3

Q33454062-10D128CA-1932-48FF-AF58-E03CF76B5B18

Q33454062-123DA4DA-3822-44AD-8072-30AF66B26767

Q33454062-209FFF3A-E0CB-48AC-96E3-20565DA599D0

Q33454062-26CEA923-8B54-4484-A94D-34FA793CF6A8

Q33454062-2C61710A-6774-447C-9DF5-5E77BB9DB96C

Q33454062-2C6B4356-2CA6-489F-894D-B06C2E83A086

Q33454062-3935BFA7-3DB2-44C7-9141-DBF500DEAE3D

Q33454062-4AAE5244-A2D2-4206-8C0E-93234F83319B

P2888

Q33454062-A1826FB6-305C-4E7B-BA92-B6DC68F1EDC0

P304

Q33454062-F0B91032-C6C3-4CEC-BD78-6DD149A4C085

P31

Q33454062-DC3AE407-7FA1-41EE-A2B1-B6DE2E6347F4

P356

Q33454062-97B5AA50-7D12-4178-8E9E-6B67F217A636

P478

Q33454062-F0B94A00-5422-4836-A7DD-5D0A0370FFB3

P577

Q33454062-3EEDBB03-2BA8-4452-BB8E-62380CE596C2

P5875

Q33454062-AE21C034-6BDB-4693-885C-1EC1C0F9972E

P6179

Q33454062-13CE2800-B69E-4DDD-AC66-58B4A662D994

P698

Q33454062-A19798BC-A1B0-47FC-A8E6-60051B527A3B

P921

Q33454062-6BBC97FB-1847-4633-BAC8-67C40FC6F4FD

P932

Q33454062-61A4B777-120E-4EEB-BD3F-A9A984265739

P356

P1433

BMC Infectious Diseases

P1476

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

@en

P2093

Ana Lucia M Sousa

http://www.w3.org/2001/XMLSchema#string

Celina T Martelli

http://www.w3.org/2001/XMLSchema#string

David M Scollard

http://www.w3.org/2001/XMLSchema#string

Jackeline G Guerra

http://www.w3.org/2001/XMLSchema#string

Maria Leide W Oliveira

http://www.w3.org/2001/XMLSchema#string

Mariane M Stefani

http://www.w3.org/2001/XMLSchema#string

Mauricio B Costa

http://www.w3.org/2001/XMLSchema#string

P2860

The continuing challenges of leprosy

Tumor necrosis factor production in patients with leprosy

Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states

IL-17 family cytokines and the expanding diversity of effector T cell lineages

Learning from lesions: patterns of tissue inflammation in leprosy.

Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions.

Panniculitis. Part II. Mostly lobular panniculitis.

Classification of leprosy according to immunity. A five-group system.

Interleukin-6: a cytokine and/or a major modulator of the response to somatic stress.

Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis.

P2888

P304

75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-9-75

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26244909

http://www.w3.org/2001/XMLSchema#string

P6179

1043596957

http://www.w3.org/2001/XMLSchema#string

P698

19473542

http://www.w3.org/2001/XMLSchema#string

P921

P932

2696458

http://www.w3.org/2001/XMLSchema#string